Baseline clinical status as a predictor of methylprednisolone response in multiple sclerosis relapses

Conclusions:
Clinical baseline status prior to MS relapse is a predictor of response to methylprednisolone treatment.

Source: Multiple Sclerosis - December 18, 2015 Category: Neurology Authors: Ramo-Tello, C., Tintore, M., Rovira, A., Ramio-Torrenta, L., Brieva, L., Saiz, A., Cano, A., Carmona, O., Hervas, J. V., Grau-Lopez, L. Tags: Short Reports Source Type: research